ABSTRACT
Objective Determine the CALL SCORE’s diagnostic accuracy for the prediction of ICU admission and death in patients hospitalized for COVID-19 pneumonia in a reference hospital in Peru.
Methods We performed an analytical cross-sectional observational study. We included patients with COVID-19 pneumonia treated at the “Dos de Mayo” National Hospital. Patients over 18 years old with a diagnosis confirmed by rapid or molecular testing were included. Those with an incomplete, illegible, or missing medical history and/or bacterial or fungal pneumonia were excluded. Data were extracted from medical records. The primary outcomes were mortality and admission to the ICU. The Call Score was calculated for each patient (4 to 13 points) and classified into three risk groups. Summary measures were presented for qualitative and quantitative variables. The area under the model curve and the operational characteristics (sensitivity, specificity) were calculated for the best cut-off point.
Results The Call Score reported an area under the curve of 0.59 (IC95%: 0.3 to 0.07), p = 0.43 for predicting death. However, for a cut-off point of 5.5, a sensitivity of 87%and a specificity of 65%were obtained. The area under the curve for ICU admission was 0.67 (95%CI: 0.3 to 0.07), p = 0.43; the 5.5 cut-off point showed a sensitivity of 82%and a specificity of 51%.
Conclusions The Call Score shows a low performance for predicting mortality and admission to the ICU in Peruvian patients.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
https://prisa.ins.gob.pe/index.php/acerca-de-prisa/busqueda-de-proyectos-de-investigacion-en-salud/1264-rendimiento-clinico-del-call-score-para-la-prediccion-de-ingreso-a-uci-y-muerte-en-pacientes-hospitalizados-con-neumonia-por-covid-19-en-un-hospital-de-referencia-en-peru
Clinical Protocols
Funding Statement
No external financing was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol was approved by the IRB of Hospital Dos de Mayo, Lima-Peru.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Dos de Mayo National Hospital Archives, Database, Lima-Peru.
http://hdosdemayo.gob.pe/portal/estadistica/boletin-epidemiologico/
https://drive.google.com/file/d/1kaLJwk4IFwYSIa28-4rRWe1WqPJg3QwS/view?usp=sharing
